DVT Clinical Trials

11 recruitingLast updated: May 13, 2026

There are 11 actively recruiting dvt clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Baghdad, Iraq, Beijing, Beijing Municipality, China, Changchun, Jilin, China. Updated daily from ClinicalTrials.gov.


DVT Trials at a Glance

11 actively recruiting trials for dvt are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Baghdad, Beijing, and Changchun. Lead sponsors running dvt studies include Argon Medical Devices, Chinese PLA General Hospital, and Al-Nahrain University.

Browse dvt trials by phase

Treatments under study

About DVT Clinical Trials

Looking for clinical trials for DVT? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new DVT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about DVT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Peripheral Arterial DiseaseDVTAcute Limb Ischemia+8 more
Medtronic Endovascular50 enrolled1 locationNCT07335341
Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Deep Vein Thrombosis (DVT)Venous EmbolismThrombus in the Peripheral Venous Vasculature+1 more
Argon Medical Devices185 enrolled3 locationsNCT07102160
Recruiting

Clinical Application of Wearable Ultrasound Sensors

DVT - Deep Vein ThrombosisPOCUS
Chinese PLA General Hospital300 enrolled1 locationNCT07009873
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting
Not Applicable

Deep Venous Thrombosis and Long Term Complications

DVT of Legs
Ove Andersen178 enrolled1 locationNCT05789108
Recruiting
Not Applicable

Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)

Deep Vein Thrombosis (DVT)
Hvidovre University Hospital152 enrolled1 locationNCT06909240
Recruiting
Not Applicable

Forceps vs. Snare IVC Filter Removal

DVT
University of Chicago100 enrolled1 locationNCT04092192
Recruiting

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

DVT - Deep Vein Thrombosis
Al-Nahrain University112 enrolled1 locationNCT06729021
Recruiting

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Johannes Gutenberg University Mainz2,000 enrolled1 locationNCT02156401
Recruiting
Phase 4

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

SurgeryDeep Vein Thrombosis (DVT)Trauma+1 more
Oregon Health and Science University606 enrolled1 locationNCT02342444
Recruiting

The Butterfly study. A trial assessing acceptability and safety of using a subcutanous catheter to administer enoxaparin (Clexane) in patients requiring long-term therapy for treatment or prevention of blood clots.

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Monash Health40 enrolled2 locationsACTRN12622001059752